Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 11, 2022 11:45 ET | Source: NFL BIOSCIENCES

NFL BIOSCIENCES confirme le renouvellement de son éligibilité au PEA-PME

NFL BIOSCIENCES confirme le renouvellement de son éligibilité au PEA-PME NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments...
June 24, 2022 12:00 ET | Source: NFL BIOSCIENCES

NFL BIOSCIENCES : PARTICIPATION À LA H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE

NFL BIOSCIENCES : PARTICIPATION À LA H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des...
June 24, 2022 12:00 ET | Source: NFL BIOSCIENCES

NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE

NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical...
May 25, 2022 02:00 ET | Source: NFL BIOSCIENCES

NFL BIOSCIENCES, which is committed to the fight against smoking, fully supports World No Tobacco Day on May 31

NFL BIOSCIENCES, which is committed to the fight against smoking, fully supports World No Tobacco Day on May 31 NFL BIOSCIENCES, a biopharmaceutical company developing botanical drugs for the...
May 25, 2022 02:00 ET | Source: NFL BIOSCIENCES

NFL BIOSCIENCES, engagé dans la lutte contre le tabagisme, souscrit pleinement à la Journée Mondiale Sans Tabac du 31 mai

NFL BIOSCIENCES, engagé dans la lutte contre le tabagisme, souscrit pleinement à la Journée Mondiale Sans Tabac du 31 mai NFL BIOSCIENCES, société biopharmaceutique développant des médicaments...
May 11, 2022 12:15 ET | Source: NFL BIOSCIENCES

NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea

NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs...
May 11, 2022 12:15 ET | Source: NFL BIOSCIENCES

NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Corée du Sud

NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Corée du Sud NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments...
April 29, 2022 11:45 ET | Source: NFL BIOSCIENCES

NFL Biosciences : Mise à disposition du Rapport Annuel au 31/12/2021

NFL Biosciences : Mise à disposition du Rapport Annuel au 31/12/2021 NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments botaniques...
April 11, 2022 12:00 ET | Source: NFL BIOSCIENCES

NFL BIOSCIENCES: Notice of allowance of its patent in China

NFL BIOSCIENCES: Notice of allowance of its patent in China NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of...
April 11, 2022 12:00 ET | Source: NFL BIOSCIENCES

NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Chine

NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Chine NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments...